Nevertheless, our data support previous findings that monitoring blood cytokine/chemokine levels, especially for IL-8 [58,61] and IP-10 [60,83], could be used as additional biomarkers to help identify and manage COVID-19 patients with different disease severities. The gene discussed is CXCL8; the disease is COVID-19.